Proteome Systems, Egenix, Sentigen, FDA, Applied Imaging, Genetix, Pfizer, PerkinElmer | GenomeWeb
Proteome Systems, Egenix Find Prostate Cancer Biomarker, Developing Test
Researchers at Proteome Systems and Egenix have identified a prostate cancer biomarker associated with human carcinoma antigen (HCA), Proteome Systems said this week.
The two companies are collaborating on a non-invasive prostate cancer diagnostic test to detect the presence of the prostate-specific glycoprotein and HCA.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.